Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Robert LauzonEstee LauderELPARTIAL BUYMar 11, 2020

He owns this one and it is now being impacted by CVT-19, due to their global sales reach. He thinks this could be a good time to buy into a position partially. Since they are located at a lot of airports, expect their sales to be impacted for now, which should cause a couple of weak quarters. A blue-chip consumer product company that you could buy today.

$173.15

Stock price when the opinion was issued

$84.64

As of Jun 18, 2026. Market Open.

Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

EL is a high-quality consumer staple name, which has always traded at a premium valuation. However, EL’s revenue has declined for two years in a row now, which has investors concerned. We think EL is in a bit of turnaround situation now, which we try to stay away from (most turnarounds rarely turn or take longer than expected), we would like to see revenue growth recover before getting interested in EL. Growth out of China is not helping but competition does look like it is increasing across the board as well and we wonder a bit if EL is having trouble adjusting to newer marketing channels that are being used. 
Unlock Premium - Try 5i Free

DON'T BUY

It used to be top of the world, offering the best luxury cosmetics like skin care. They made a big bet on Chinese travellers returning to duty-free shops, but they lost the bet. Meanwhile, competitors came on hard. IS down 44% this year, though popped 5% today.

BUY

It's been a loser for him, but it does a lot of business in China. Shares moved up before and after today's Biden-Xi summit. It's one of the biggest market laggards, and now the market is looking for those.

DON'T BUY

A disaster. Used to be great. The CEO is not doing a good job.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

EL’s share price is under tremendous pressure recently due to the weak guidance. Still, at 52X earnings the stock is still on the expensive side, even with a 28% YTD decline.  Based on consensus estimates, sales are expected to decline by around -10% this year and start to recover back to 2022’s level in 2024. We think EL still possesses a strong portfolio of worldwide recognized brands for skincare, makeup, fragrance, etc. and these brands have been around for decades and demonstrated consumer loyalty and significant pricing power over the years. Most consumer discretionary names experienced a short-term headwind due to the concern of economic recession. In the last quarter EPS missed estimates. For 2023, EPS is expected to decline by close to 50%. But, nearly 50% growth is expected in a 2024 recovery. Thus, this is a tough call. Momentum is negative, and there are still risks. Valuation is high, but we think that is because investors believe in the rebound possibility. We have recession risk, but the balance sheet is OK (some debt but not an onerous amount). Sentinment is very negative, so any positive news at all should be good for the stock. We would thus be willing to hold to see how the next two quarters fare. 
Unlock Premium - Try 5i Free

HOLD

Upgraded today, but down 25% YTD. It has missed the last three quarters and most recently guided down due to supply chain issues and China reopening slowly and travel retail (mostly from Asia) being down 43%. But ex-travel retail rose 10% last quarter, so eventually these will work. Eventually, China will right itself and sentiment has fallen enough.

DON'T BUY

Is linked to China whose reopening has been much slower than expected, so EL isn't doing well lately. 

BUY ON WEAKNESS
Allan Tong’s Discover Picks

It’s a safe bet to assume that the return of the Chinese traveller will boost EL’s bottom line. Rather, it’s a question of how much and how fast? The company itself has beaten its last four quarters. The market is giving shares the benefit of the doubt as EL trades just under 58x PE, above its five-year average of 55.31x and higher than in 2022, but a third during the December 2020 peak. Read China reopens for our full analysis.

BUY

Expects a good quarter next week.

BUY

Will benefit from China's reopening and has long performed well there. 

BUY
SBUX and Estee Lauder

Today marks the first day that American business executives can fly to China after three years. Those American companies which already have a strong presence in China can get a major boost from this reopening. The company was thriving before the reopening, so imagine what happens now.

BUY
Down 33% so far this year, due China's lockdowns (a major market). Covid could explode there, then subside, because that's what Covid does. Has rebounded 37% from last month's lows. This looks great for 2023.
COMMENT
It reports next week. Eager to hear results. She doesn't own a lot of consumer discretionary. It's a prestige brand and could grow its market share and margins over time, but even though the PE is pricey. Problem is they rely on China where Covid restrictions are an overhang.
PARTIAL SELL
She trimmed this due to issues in China. Trades at an expensive 36x PE. She just sold some shares.
BUY
The return of travel and possible loosening of restrictions in China are tailwinds.